Liquid biopsy has emerged as a novel approach to tumor characterization, offering advantages in sample accessibility and tissue heterogeneity. However, as mutational analysis predominates, the tumor microenvironment has largely remained unacknowledged in liquid biopsy research.
This white paper from Biotech Support Group describes how it may be possible to create a liquid biopsy-based clinical tool to provide relevant information about the state of the tumor microenvironment to accurately quantify intra-tumoral stromal content at numerous time points from a noninvasive blood draw.
Offered Free by: Biotech Support Group LLC
See All Resources from: Biotech Support Group LLC